Innate Immune Recognition of B. anthracis

炭疽芽孢杆菌的先天免疫识别

基本信息

  • 批准号:
    7530781
  • 负责人:
  • 金额:
    $ 22.73万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-06-09 至 2010-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Concerns resulting from the human anthrax cases in the Fall of 2001 have increased our need for a more complete understanding of the host response to Bacillus anthracis infection following aerosol exposure. The mechanism by which B. anthracis kills the host remains unknown, but mortality is high following aerosol exposure even when appropriate antibiotics are administered. This suggests that B. anthracis may be capable of evading or subverting one or more elements of the host response following infection. The innate immune system typically provides the first recognition of and defense against invading pathogens. Host innate immune cells have a repertoire of receptors for sensing, recognizing, and initiating responses to invading pathogens; these receptors include Toll-like receptors and intracellular NOD receptors. The overall goal of this project is to advance our understanding of the host innate immune response to B. anthracis. With a better understanding of the immune recognition pathways and host immune response, our future goal will be to identify immunomodulatory strategies to help prevent the rapid, sudden death typically observed in a host infected with B. anthracis. The specific goals of this proposal are to identify those host innate immune receptors that recognize B. anthracis spores and bacilli. In Specific Aim 1, we will determine the pathways and receptors activated by the interaction of the organism with the host using cell lines transfected with selected receptors. Preliminary results implicate Toll-like receptor 2 and MyD88-dependent pathways in this response. In Specific Aim 2, we will determine the contribution of the relevant innate immune receptors including Toll-like receptor 2 to protection of the host from inhalational anthrax infection using a mouse aerosol challenge model. A more complete understanding of the interaction of B. anthracis with the host will allow us to evaluate animal-based studies of B. anthracis vaccines and therapeutics, provide a foundation for the development of anthrax-directed immunotherapeutics, and provide important fundamental information applicable to a diverse group of bacterial pathogens. PUBLIC HEALTH RELEVANCE: Bacillus anthracis is the bacterial pathogen that causes anthrax. The inhaled form of anthrax typically results in sudden death of the host in spite of early recognition of the infection by healthcare workers and early use of antibiotics, as was seen with the anthrax cases in the Fall of 2001. The goal of this research is to determine how Bacillus anthracis interacts with the host's immune system in order to devise strategies for healthcare workers to help fight the infection.
描述(由申请人提供):2001年秋季人类炭疽病例引起的关注增加了我们对气溶胶暴露后宿主对炭疽芽孢杆菌感染反应的更全面了解的需求。炭疽芽胞杆菌杀死宿主的机制尚不清楚,但即使给予适当的抗生素,接触气溶胶后死亡率也很高。这表明炭疽芽胞杆菌可能能够在感染后逃避或破坏宿主反应的一个或多个要素。先天免疫系统通常提供对入侵病原体的第一个识别和防御。宿主先天免疫细胞具有一系列受体,用于感知、识别和启动对入侵病原体的反应;这些受体包括toll样受体和细胞内NOD受体。该项目的总体目标是促进我们对宿主对炭疽杆菌的先天免疫反应的理解。随着对免疫识别途径和宿主免疫反应的更好理解,我们未来的目标将是确定免疫调节策略,以帮助预防在感染炭疽芽胞杆菌的宿主中通常观察到的快速,突然死亡。本建议的具体目标是鉴定识别炭疽芽孢杆菌和芽孢杆菌的宿主先天免疫受体。在特异性目标1中,我们将使用转染了选定受体的细胞系确定生物体与宿主相互作用激活的途径和受体。初步结果提示toll样受体2和myd88依赖性通路参与了该反应。在特异性目标2中,我们将使用小鼠气溶胶攻击模型确定包括toll样受体2在内的相关先天免疫受体对保护宿主免受吸入性炭疽感染的贡献。更全面地了解炭疽杆菌与宿主的相互作用,将使我们能够评估以动物为基础的炭疽杆菌疫苗和治疗方法的研究,为炭疽定向免疫治疗的发展提供基础,并提供适用于多种细菌病原体的重要基础信息。公共卫生相关性:炭疽芽孢杆菌是引起炭疽的细菌病原体。吸入形式的炭疽通常会导致宿主突然死亡,尽管卫生保健工作者早期识别感染并早期使用抗生素,如2001年秋季炭疽病例所见。这项研究的目的是确定炭疽芽孢杆菌如何与宿主的免疫系统相互作用,以便为医护人员设计帮助对抗感染的策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MOLLY A HUGHES其他文献

MOLLY A HUGHES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MOLLY A HUGHES', 18)}}的其他基金

A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
重塑抗生素模型的独特策略:针对宿主和病原体的趋化因子启发疗法,对抗多重耐药细菌引起的感染
  • 批准号:
    10468194
  • 财政年份:
    2020
  • 资助金额:
    $ 22.73万
  • 项目类别:
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
重塑抗生素模型的独特策略:针对宿主和病原体的趋化因子启发疗法,对抗多重耐药细菌引起的感染
  • 批准号:
    10676878
  • 财政年份:
    2020
  • 资助金额:
    $ 22.73万
  • 项目类别:
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
重塑抗生素模型的独特策略:针对宿主和病原体的趋化因子启发疗法,对抗多重耐药细菌引起的感染
  • 批准号:
    10120102
  • 财政年份:
    2020
  • 资助金额:
    $ 22.73万
  • 项目类别:
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
重塑抗生素模型的独特策略:针对宿主和病原体的趋化因子启发疗法,对抗多重耐药细菌引起的感染
  • 批准号:
    10269939
  • 财政年份:
    2020
  • 资助金额:
    $ 22.73万
  • 项目类别:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
炭疽杆菌靶标参与趋化因子介导的抗菌活性
  • 批准号:
    8646871
  • 财政年份:
    2013
  • 资助金额:
    $ 22.73万
  • 项目类别:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
炭疽杆菌靶标参与趋化因子介导的抗菌活性
  • 批准号:
    8822201
  • 财政年份:
    2013
  • 资助金额:
    $ 22.73万
  • 项目类别:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
炭疽杆菌靶标参与趋化因子介导的抗菌活性
  • 批准号:
    8435665
  • 财政年份:
    2013
  • 资助金额:
    $ 22.73万
  • 项目类别:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
炭疽杆菌靶标参与趋化因子介导的抗菌活性
  • 批准号:
    9029273
  • 财政年份:
    2013
  • 资助金额:
    $ 22.73万
  • 项目类别:
2011 Chemical & Biological Terrorism Defense Gordon Research Conference (GRC) and
2011年化学
  • 批准号:
    8052353
  • 财政年份:
    2010
  • 资助金额:
    $ 22.73万
  • 项目类别:
2009 Chemical and Biological Terrorism Defense Gordon Research Conference
2009年化学和生物恐怖主义防御戈登研究会议
  • 批准号:
    7608881
  • 财政年份:
    2008
  • 资助金额:
    $ 22.73万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 22.73万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 22.73万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.73万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 22.73万
  • 项目类别:
    Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
  • 批准号:
    2889694
  • 财政年份:
    2023
  • 资助金额:
    $ 22.73万
  • 项目类别:
    Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 22.73万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 22.73万
  • 项目类别:
    Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 22.73万
  • 项目类别:
    Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 22.73万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 22.73万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了